Skip to content
Toggle main navigation
PURPOSE logo
PURPOSE logo
  • Home
  • Events
  • Opportunities
  • News & Publications
  • T90/R90 HEAL Pain Cohort Program
  • Mobile App
  • About
  • Exhibit
  • Affiliate Networks
    • Music4Pain (U24)
    • ENSEMBLE Network (U24)
    • Pain Research Forum (PRF)
    • ForceNET (U24)
    • NeuronS_MATTR (U24)
    • SPINEWORK Network (U24)
    Log in
    Request to Join

    News & Publications

    Do you have news or publications to share with the PURPOSE Network? Submit your news below.

    Submit Your News or Publication
    All
    Acquired Cognitive Impairment
    Acupuncture
    Addiction
    Ageing
    Alcohol Use / Alcohol Use Disorder (AUD)
    Analgesics
    Analgesics, Topical
    Anatomy
    Anesthesia, General
    Anesthesia, Intravenous regional
    Anesthesia, Local
    Anesthesia, Spinal
    Animal Models
    Anxiety
    Arthritis, Rheumatoid
    See all

    Highlighted News

    Results (9)

    Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Pain Management: A Narrative Review

    Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Pain Management: A Narrative Review

    Curr Neuropharmacol. 2026 Sep 29. doi: 10.2174/011570159X503412260915114332. Online ahead of print.ABSTRACTChronic pain represents a global public health challenge; current therapeutic interventions remain limited and are frequently accompanied by adverse effects. Transcutaneous auricular Vagus Nerve Stimulation (taVNS) has emerged in recent years as a potential non-invasive neuromodulation therap
    October 1, 2026
    Distinct parafascicular neuronal ensembles mediate the sensory and affective dimensions of trigeminal neuralgia

    Distinct parafascicular neuronal ensembles mediate the sensory and affective dimensions of trigeminal neuralgia

    Source: The Journal of clinical investigationAuthors: Yitian Lu, Yangyang Yi, Jiao Liu, Hao Zhi, Qing Chang, Zihao Huang, Yumeng Chen, Han L Tan, Yiheng Tu, Yun Wang, Cheng Cen, Publication Date: Tue, 14 Jul 2026 06:00:00 -0400J Clin Invest. 2026 Jul 14:e206862. doi: 10.1172/JCI206862. Online ahead of print.ABSTRACTTrigeminal neuralgia (TN) is a severe orofacial pain disorder accompanied by anxiet
    July 17, 2026
    Nasal Neurostimulation as an Adjunct Novel Treatment for Oculofacial Pain in Herpes Zoster Ophthalmicus-Related Postherpetic Neuralgia

    Nasal Neurostimulation as an Adjunct Novel Treatment for Oculofacial Pain in Herpes Zoster Ophthalmicus-Related Postherpetic Neuralgia

    Neuromodulation. 2026 Apr 13:S1094-7159(26)00082-6. doi: 10.1016/j.neurom.2026.04.002. Online ahead of print.ABSTRACTOBJECTIVES: This study describes the effect of nasal neurostimulation in five cases of postherpetic neuralgia (PHN) after herpes zoster ophthalmicus.MATERIALS AND METHODS: This retrospective case series included five symptomatic patients with PHN who were receiving conventional pain
    June 25, 2026
    Prognostic impact of multi-divisional trigeminal neuralgia on pain outcomes following microvascular decompression

    Prognostic impact of multi-divisional trigeminal neuralgia on pain outcomes following microvascular decompression

    Clin Neurol Neurosurg. 2026 Jun 15;269:109543. doi: 10.1016/j.clineuro.2026.109543. Online ahead of print.ABSTRACTOBJECTIVE: Microvascular decompression (MVD) is the gold standard surgical treatment for medically refractory trigeminal neuralgia (TN). Pain distribution in TN is heterogeneous, with multi-divisional involvement representing a substantial patient subset; however, whether division patt
    June 19, 2026
    Nomogram prediction model for pain recurrence in patients with trigeminal neuralgia after microvascular decompression

    Nomogram prediction model for pain recurrence in patients with trigeminal neuralgia after microvascular decompression

    Neurosurg Rev. 2026 Jun 19;49(1):453. doi: 10.1007/s10143-026-04368-w.ABSTRACTMicrovascular decompression (MVD) is the first-line surgical treatment for trigeminal neuralgia (TN). However, some patients experience recurrence despite achieving immediate pain relief after MVD. This study aimed to identify the risk factors for TN recurrence and to develop a predictive nomogram model. We enrolled pati
    June 19, 2026
    Differentiating Trigeminal Neuralgia From Persistent Idiopathic Dentoalveolar Pain and Persistent Idiopathic Facial Pain in Oral and Maxillofacial Surgery

    Differentiating Trigeminal Neuralgia From Persistent Idiopathic Dentoalveolar Pain and Persistent Idiopathic Facial Pain in Oral and Maxillofacial Surgery

    J Oral Maxillofac Surg. 2026 Jun;84(6):823-825. doi: 10.1016/j.joms.2026.01.075.ABSTRACTThe diagnostic distinction between trigeminal neuralgia (TN), persistent idiopathic dentoalveolar pain, and persistent idiopathic facial pain remains a challenge for oral and maxillofacial surgeons. While neurovascular compression is often viewed as a definitive indicator for surgical intervention, recent evide
    June 5, 2026
    Deep brain stimulation for chronic pain: a narrative review

    Deep brain stimulation for chronic pain: a narrative review

    Neurochirurgie. 2026 May 20:101831. doi: 10.1016/j.neuchi.2026.101831. Online ahead of print.ABSTRACTAlthough Deep brain stimulation (DBS) is commonly used in movement disorders, it was originally developed in the 1970s to treat medically-refractory chronic pain. There are still indications for DBS, including refractory facial neuropathic pain, central neuropathic pain, brachial plexus avulsion pa
    May 22, 2026
    Elevated Plasma Vitamin D Levels are Associated with Pain Characteristics and Duration in Patients with Postherpetic Neuralgia

    Elevated Plasma Vitamin D Levels are Associated with Pain Characteristics and Duration in Patients with Postherpetic Neuralgia

    Clin Lab. 2026 May 1;72(5). doi: 10.7754/Clin.Lab.2025.250402.ABSTRACTBACKGROUND: Aim is to analyze the correlation between plasma vitamin D (VD) level and pain characteristics and duration in patients with postherpetic neuralgia (PHN).METHODS: 116 patients with PHN were prospectively collected as the PHN group, and another 102 non-PHN patients were selected as the control group. The plasma VD lev
    May 20, 2026
    Sciatica beyond the spine: a prospective study on laparoscopic neurolysis of pelvic sciatic and sacral nerves demonstrating long-term improvements in pain, function, mood, and bladder symptoms (VAS, SF-36, PHQ-9, OAB-V8)

    Sciatica beyond the spine: a prospective study on laparoscopic neurolysis of pelvic sciatic and sacral nerves demonstrating long-term improvements in pain, function, mood, and bladder symptoms (VAS, SF-36, PHQ-9, OAB-V8)

    Eur Spine J. 2026 May 13. doi: 10.1007/s00586-026-09943-9. Online ahead of print.ABSTRACTBACKGROUND: Intrapelvic entrapment of the sciatic and sacral nerve roots can cause chronic pelvic pain, sciatica, and symptoms such as dysmenorrhea, dyspareunia, dyschezia, dysuria, vulvodynia, coccygodynia, and pudendal neuralgia. Conventional spine-focused approaches often overlook this cause. This study ass
    May 13, 2026
    Contact
    Neurovations Education
    [email protected]

    United States

    PURPOSE@PainResearchers.com
    707-260-0848
    Links
    • NIH HEAL Initiative
    • Research in Pain Management